🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.

Platform Reaction and Material Elimination

According to the social media company, the platform has removed violative content and prohibited associated keywords and query recommendations. The company said it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Digital Marketplace Activities

Research also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, filled with images of slimming results, positive testimonials and detailed guides for preparing or injecting at residence.

After minutes of joining one community, a seller posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about weight, health issues or past usage.

Product Information and Pricing

Inside these groups, posts show black plastic parcels with postal service labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service stated it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not include what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her team has previously seen individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from Eli Lilly stated the substance was in phase 3 research studies and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to potentially serious medical dangers”.